Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 117.05
-1.41 %
$ 11.7 B
Market Cap
35.58
P/E
NBIX - NET CHANGE IN CASH
Net Change in Cash NBIX - Neurocrine Biosciences, Inc.
-18.1 M
LAST VALUE
50.31%
2 YEAR CAGR
10.61%
5 YEAR CAGR
-2.77%
10 YEAR CAGR